JP2014523854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523854A5 JP2014523854A5 JP2014504057A JP2014504057A JP2014523854A5 JP 2014523854 A5 JP2014523854 A5 JP 2014523854A5 JP 2014504057 A JP2014504057 A JP 2014504057A JP 2014504057 A JP2014504057 A JP 2014504057A JP 2014523854 A5 JP2014523854 A5 JP 2014523854A5
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- aromatic compound
- polymer
- liposome composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002502 liposome Substances 0.000 claims 20
- 150000001491 aromatic compounds Chemical class 0.000 claims 13
- 150000003904 phospholipids Chemical class 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 230000002708 enhancing effect Effects 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 230000002285 radioactive effect Effects 0.000 claims 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 6
- 239000012528 membrane Substances 0.000 claims 6
- 208000037259 Amyloid Plaque Diseases 0.000 claims 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 235000012000 cholesterol Nutrition 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- -1 carboxy, sulfonyl Chemical group 0.000 claims 2
- 239000013522 chelant Substances 0.000 claims 2
- 125000003147 glycosyl group Chemical group 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 claims 2
- 229960004359 iodixanol Drugs 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 claims 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims 1
- 229910052688 Gadolinium Inorganic materials 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000002591 computed tomography Methods 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000002595 magnetic resonance imaging Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161472605P | 2011-04-06 | 2011-04-06 | |
| US61/472,605 | 2011-04-06 | ||
| PCT/US2012/032649 WO2012139080A2 (en) | 2011-04-06 | 2012-04-06 | Lipid-based nanoparticles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017176383A Division JP6533813B2 (ja) | 2011-04-06 | 2017-09-14 | 脂質ベースのナノ粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014523854A JP2014523854A (ja) | 2014-09-18 |
| JP2014523854A5 true JP2014523854A5 (enExample) | 2014-10-30 |
| JP6212032B2 JP6212032B2 (ja) | 2017-10-18 |
Family
ID=46966277
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504057A Expired - Fee Related JP6212032B2 (ja) | 2011-04-06 | 2012-04-06 | 脂質ベースのナノ粒子 |
| JP2017176383A Expired - Fee Related JP6533813B2 (ja) | 2011-04-06 | 2017-09-14 | 脂質ベースのナノ粒子 |
| JP2019098174A Pending JP2019151664A (ja) | 2011-04-06 | 2019-05-27 | 脂質ベースのナノ粒子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017176383A Expired - Fee Related JP6533813B2 (ja) | 2011-04-06 | 2017-09-14 | 脂質ベースのナノ粒子 |
| JP2019098174A Pending JP2019151664A (ja) | 2011-04-06 | 2019-05-27 | 脂質ベースのナノ粒子 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9801957B2 (enExample) |
| EP (2) | EP3366313A1 (enExample) |
| JP (3) | JP6212032B2 (enExample) |
| KR (2) | KR101973063B1 (enExample) |
| CN (1) | CN104144708B (enExample) |
| AU (3) | AU2012239888B9 (enExample) |
| BR (1) | BR112013025633A2 (enExample) |
| CA (1) | CA2831480C (enExample) |
| DK (1) | DK2694116T3 (enExample) |
| ES (1) | ES2685824T3 (enExample) |
| MX (1) | MX357227B (enExample) |
| PL (1) | PL2694116T3 (enExample) |
| PT (1) | PT2694116T (enExample) |
| WO (1) | WO2012139080A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2694116T3 (pl) | 2011-04-06 | 2018-12-31 | Board Of Regents Of The University Of Texas System | Nanocząstki na bazie lipidów |
| MX366972B (es) | 2012-01-20 | 2019-08-01 | Ananth Annapragada | Metodos y composiciones para caracterizar imagenes medicas en forma objetiva. |
| US9512092B2 (en) * | 2013-12-12 | 2016-12-06 | Albert Einstein College Of Medicine, Inc. | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof |
| AU2015330824A1 (en) * | 2014-10-08 | 2017-05-25 | Ananth Annapragada | MRI imaging of amyloid plaque using liposomes |
| GB201509934D0 (en) | 2015-06-08 | 2015-07-22 | King S College London | Nanoparticles |
| CN109414451B (zh) * | 2016-05-16 | 2022-08-12 | 德克萨斯大学系统董事会 | 用于作为纳米粒递送tRNA的组合物及其使用方法 |
| EP3548002B1 (en) | 2016-11-30 | 2025-04-30 | Texas Children's Hospital | Hydrophilic fluorinated molecules for liposomal 19f mri probes with unique mr signatures |
| US20200261605A1 (en) * | 2019-01-24 | 2020-08-20 | Alzeca Biosciences, LLC | Functionalized liposomes for imaging misfolded proteins |
| US11116854B2 (en) * | 2020-01-29 | 2021-09-14 | Texas Children's Hospital | Targeted contrast agents for MRI of amyloid deposition |
| US11779664B2 (en) | 2020-02-12 | 2023-10-10 | Texas Children's Hospital | Targeted contrast agents for MRI of alpha-synuclein deposition |
| KR20230012461A (ko) | 2020-02-12 | 2023-01-26 | 텍사스 칠드런스 하스피탈 | 알파-시누클레인 침착의 mri를 위한 표적화된 조영제 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4331751A (en) * | 1980-11-17 | 1982-05-25 | Eastman Kodak Company | Electrically photosensitive materials and elements for photoelectrophoretic imaging processes |
| US5204085A (en) | 1985-01-08 | 1993-04-20 | Mallinckrodt Medical, Inc. | Method for enhancing the safety of metal-ligand chelates as X-ray contrast agents |
| US5674468A (en) | 1992-03-06 | 1997-10-07 | Nycomed Imaging As | Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons |
| AU2076895A (en) | 1994-03-28 | 1995-10-17 | Daiichi Pharmaceutical Co., Ltd. | Liposomes |
| US6071532A (en) | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| ATE287700T1 (de) * | 1999-11-30 | 2005-02-15 | Univ Arizona | Strahlung-sensitive liposomen |
| AU2002211517A1 (en) * | 2000-10-04 | 2002-04-15 | California Institute Of Technology | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| US6821504B2 (en) * | 2001-05-23 | 2004-11-23 | New York University | Detection of alzheimer's amyloid by magnetic resonance imaging |
| EP1480691A4 (en) | 2002-03-05 | 2007-11-28 | Univ State Cleveland | AGGLOMERATED PARTICLES FOR THE DISPOSAL OF A MEDICINAL PRODUCT IN AEROSOL FORM |
| EP1641742A4 (en) | 2003-05-01 | 2006-11-29 | Nst Neurosurvival Technologies | COMPOUNDS BINDING SELECTIVELY TO MEMBRANES OF APOPTOTIC CELLS |
| US7208174B2 (en) * | 2003-12-18 | 2007-04-24 | Hoffmann-La Roche Inc. | Liposome compositions |
| US20100031378A1 (en) | 2008-08-04 | 2010-02-04 | Edwards Joel A | Novel gene disruptions, compositions and methods relating thereto |
| US8357351B2 (en) | 2004-04-21 | 2013-01-22 | Ananth Annapragada | Nano-scale contrast agents and methods of use |
| US7713517B2 (en) | 2004-04-21 | 2010-05-11 | Marval Biosciences, Inc. | Compositions and methods for enhancing contrast in imaging |
| WO2006026184A2 (en) * | 2004-08-20 | 2006-03-09 | Washington University | Blood brain barrier permeation peptides |
| US20070292354A1 (en) * | 2004-09-23 | 2007-12-20 | Guerbet | Contrast Agents Encapsulating Systems for Cest Imaging |
| US9943481B2 (en) * | 2005-05-26 | 2018-04-17 | Biorest Ltd. | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier |
| US20070160658A1 (en) * | 2005-10-20 | 2007-07-12 | The Penn State Research Foundation | Delivery system for diagnostic and therapeutic agents |
| EP2010223A2 (en) | 2006-04-07 | 2009-01-07 | The Board Of Trustees Of The University Of Illinois | Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| US20090123047A1 (en) | 2007-03-21 | 2009-05-14 | Yfantis Spyros A | Method and system for characterizing prostate images |
| EP1982733A1 (en) | 2007-04-17 | 2008-10-22 | Bayer Schering Pharma Aktiengesellschaft | Use of a contrast agent for magnetic resonance imaging of endoleaks |
| WO2009015397A1 (en) | 2007-07-26 | 2009-01-29 | Nanoscan Imaging, Llc | Methods for imaging using improved nanoparticulate contrast agents |
| EP2217146A4 (en) | 2007-12-05 | 2015-10-14 | Marval Biosciences Inc | NANOMETRIC SCALE CONTRAST AGENTS AND METHODS OF USE |
| EP2242505A4 (en) | 2008-01-08 | 2012-03-07 | Biogenerix Ag | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES |
| ITMI20081052A1 (it) * | 2008-06-10 | 2009-12-11 | Univ Milano Bicocca | Liposomi in grado di legare efficacemente il peptide beta-amiloide |
| AU2009257279A1 (en) * | 2008-06-13 | 2009-12-17 | Marval Biosciences, Inc. | Imaging of atherosclerotic plaques using liposomal imaging agents |
| WO2010017094A2 (en) * | 2008-07-31 | 2010-02-11 | The General Hospital Corporation | CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING |
| AR074760A1 (es) | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| EP2410990A4 (en) | 2009-03-19 | 2015-05-20 | Marval Biosciences Inc | COMPOSITIONS AND METHODS FOR CONTRAST GAINING IN IMAGING |
| US9334304B2 (en) * | 2009-04-02 | 2016-05-10 | The Johns Hopkins University | Self-assembling peptides bearing organic electronic functionality and applications employing the same |
| ES2620177T3 (es) | 2009-10-15 | 2017-06-27 | Guerbet | Agentes de formación de imágenes y su uso para el diagnóstico in vivo de enfermedades neurodegenerativas, particularmente la enfermedad de Alzheimer y enfermedades derivadas |
| JP5746334B2 (ja) | 2010-06-16 | 2015-07-08 | シマベイ セラピューティクス， インコーポレーテッド | Ｇｐｒ１２０受容体作動薬及びその使用 |
| US8679531B2 (en) | 2011-03-02 | 2014-03-25 | Ananth Annapragada | Vesicle compositions |
| PL2694116T3 (pl) | 2011-04-06 | 2018-12-31 | Board Of Regents Of The University Of Texas System | Nanocząstki na bazie lipidów |
| GB201112056D0 (en) | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| MX366972B (es) | 2012-01-20 | 2019-08-01 | Ananth Annapragada | Metodos y composiciones para caracterizar imagenes medicas en forma objetiva. |
| WO2013164763A2 (en) | 2012-04-30 | 2013-11-07 | Innovative Health Diagnostics | A biological complex specific for alzheimer's disease detection in vitro and use thereof |
| MX2015011677A (es) | 2013-03-14 | 2016-07-08 | Celtaxsys Inc | Inhibidores de leucotrieno a4 hidrolasa. |
| AU2015330824A1 (en) | 2014-10-08 | 2017-05-25 | Ananth Annapragada | MRI imaging of amyloid plaque using liposomes |
-
2012
- 2012-04-06 PL PL12767275T patent/PL2694116T3/pl unknown
- 2012-04-06 US US13/441,816 patent/US9801957B2/en not_active Expired - Fee Related
- 2012-04-06 JP JP2014504057A patent/JP6212032B2/ja not_active Expired - Fee Related
- 2012-04-06 MX MX2013011231A patent/MX357227B/es active IP Right Grant
- 2012-04-06 PT PT12767275T patent/PT2694116T/pt unknown
- 2012-04-06 WO PCT/US2012/032649 patent/WO2012139080A2/en not_active Ceased
- 2012-04-06 KR KR1020137029510A patent/KR101973063B1/ko not_active Expired - Fee Related
- 2012-04-06 EP EP18167725.3A patent/EP3366313A1/en not_active Withdrawn
- 2012-04-06 DK DK12767275.6T patent/DK2694116T3/en active
- 2012-04-06 KR KR1020197007384A patent/KR102035187B1/ko not_active Expired - Fee Related
- 2012-04-06 EP EP12767275.6A patent/EP2694116B1/en not_active Not-in-force
- 2012-04-06 BR BR112013025633A patent/BR112013025633A2/pt not_active Application Discontinuation
- 2012-04-06 ES ES12767275.6T patent/ES2685824T3/es active Active
- 2012-04-06 CN CN201280017548.6A patent/CN104144708B/zh not_active Expired - Fee Related
- 2012-04-06 CA CA2831480A patent/CA2831480C/en not_active Expired - Fee Related
- 2012-04-06 AU AU2012239888A patent/AU2012239888B9/en not_active Ceased
-
2017
- 2017-09-14 JP JP2017176383A patent/JP6533813B2/ja not_active Expired - Fee Related
- 2017-09-21 AU AU2017232156A patent/AU2017232156C1/en not_active Ceased
-
2019
- 2019-05-27 JP JP2019098174A patent/JP2019151664A/ja active Pending
- 2019-10-08 AU AU2019246775A patent/AU2019246775A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014523854A5 (enExample) | ||
| Forte et al. | Radiolabeled PET/MRI nanoparticles for tumor imaging | |
| Weichert et al. | Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy | |
| Lee et al. | Europium-diethylenetriaminepentaacetic acid loaded radioluminescence liposome nanoplatform for effective radioisotope-mediated photodynamic therapy | |
| US20190021608A1 (en) | CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in Humans | |
| KR102035187B1 (ko) | 지질-기반 나노입자들 | |
| JP2010523599A5 (enExample) | ||
| JP2014518861A5 (enExample) | ||
| WO2007124131A3 (en) | Hybrid nanomaterials as multimodal imaging contrast agents | |
| Georgiadou et al. | Octadecylamine-mediated versatile coating of CoFe2O4 NPs for the sustained release of anti-inflammatory drug naproxen and in vivo target selectivity | |
| EP3169792A2 (en) | Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same | |
| RU2013105799A (ru) | Липидный бислойный носитель для лекарственных средств и визуализирующих агентов | |
| JP2019535754A5 (enExample) | ||
| WO2016118188A1 (en) | Compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells | |
| JP2011500717A5 (enExample) | ||
| WO2016011419A1 (en) | Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis | |
| RU2012124266A (ru) | Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb) | |
| AR054506A1 (es) | Composiciones que contienen particulas magneticas de oxido de hierro y uso de dichas composiciones en metodos de diagnostico por imagenes | |
| JP2010524857A5 (enExample) | ||
| CN111447955A (zh) | 99mTc-替马诺塞和相关的分子构建体用于鉴定和诊断恶性肿瘤和用于监测治疗性抗肿瘤干预的用途 | |
| CN103007303A (zh) | 核-壳型三模态纳米造影剂、其制备方法及应用 | |
| Kubeil et al. | Dual-labelling strategies for nuclear and fluorescence molecular imaging: current status and future perspectives | |
| JP2018523657A5 (enExample) | ||
| TW202200216A (zh) | 用於影像引導放射治療的方法 | |
| KR20130080245A (ko) | 암 진단용 ｍｒｉ／ｃｔ 이중 조영제 및 그 제조방법 |